Cerevel Therapeutics Holdings(CERE) - 2023 Q3 - Earnings Call Presentation

Forward-Looking Statements Cerevel: Becoming the premier neuroscience company • Raised $499 million net proceeds from public offering of common stock in October 2023 © Cerevel Therapeutics Holdings, Inc. 2 Forward-looking statements in this presentation include, but are not limited to, statements about: the potential attributes and benefits of our product candidates; the format, timing and objectives of our product development activities and clinical trials; the timing and outcome of regulatory interactions ...